AT299914B - Verfahren zur Herstellung von neuen racemischen oder optisch aktiven, substituierten 3-Carbamoylphenoxy-2-hydroxy-aminopropanen, und von deren Säureadditionssalzen - Google Patents

Verfahren zur Herstellung von neuen racemischen oder optisch aktiven, substituierten 3-Carbamoylphenoxy-2-hydroxy-aminopropanen, und von deren Säureadditionssalzen

Info

Publication number
AT299914B
AT299914B AT1059870A AT1059870A AT299914B AT 299914 B AT299914 B AT 299914B AT 1059870 A AT1059870 A AT 1059870A AT 1059870 A AT1059870 A AT 1059870A AT 299914 B AT299914 B AT 299914B
Authority
AT
Austria
Prior art keywords
aminopropanes
carbamoylphenoxy
hydroxy
substituted
preparation
Prior art date
Application number
AT1059870A
Other languages
English (en)
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Application granted granted Critical
Publication of AT299914B publication Critical patent/AT299914B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT1059870A 1968-07-18 1969-07-18 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven, substituierten 3-Carbamoylphenoxy-2-hydroxy-aminopropanen, und von deren Säureadditionssalzen AT299914B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB34255/68A GB1269775A (en) 1968-07-18 1968-07-18 Alkanolamine derivatives

Publications (1)

Publication Number Publication Date
AT299914B true AT299914B (de) 1972-07-10

Family

ID=10363358

Family Applications (2)

Application Number Title Priority Date Filing Date
AT692769A AT296256B (de) 1968-07-18 1969-07-18 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven substituierten 3-Carbamoylphenoxy-2-hydroxy-aminopropanen und von deren Säureadditionssalzen
AT1059870A AT299914B (de) 1968-07-18 1969-07-18 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven, substituierten 3-Carbamoylphenoxy-2-hydroxy-aminopropanen, und von deren Säureadditionssalzen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT692769A AT296256B (de) 1968-07-18 1969-07-18 Verfahren zur Herstellung von neuen racemischen oder optisch aktiven substituierten 3-Carbamoylphenoxy-2-hydroxy-aminopropanen und von deren Säureadditionssalzen

Country Status (16)

Country Link
US (1) US3676493A (de)
JP (1) JPS4842869B1 (de)
AT (2) AT296256B (de)
BE (1) BE736231A (de)
BR (1) BR6910824D0 (de)
CH (3) CH533596A (de)
DE (1) DE1936693A1 (de)
ES (1) ES369624A1 (de)
FR (1) FR2013209A1 (de)
GB (1) GB1269775A (de)
IE (1) IE33184B1 (de)
IL (1) IL32640A (de)
NL (1) NL6910914A (de)
NO (1) NO125445B (de)
PL (1) PL80101B1 (de)
ZA (1) ZA694631B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5231858B1 (de) * 1969-12-17 1977-08-17
GB1312055A (en) * 1970-04-20 1973-04-04 Ici Ltd Alkanolamine derivatives
DE2324176A1 (de) * 1973-05-12 1974-11-28 Bayer Ag Neue katalysatoren und ihre verwendung bei der herstellung von polyurethanen
GB1460593A (en) * 1973-06-22 1977-01-06 Ici Ltd Ethanolamine derivatives
GB1413911A (en) * 1973-08-18 1975-11-12 Pfizer Ltd Preparation of propanolamine derivatives
FI65987C (fi) * 1973-12-12 1984-08-10 Ici Ltd Foerfarande foer framstaellning av nya terapeutiskt anvaendbara alkanolaminderivat
US4165384A (en) * 1974-11-01 1979-08-21 Aktiebolaget Hassle Amide substituted phenoxy propanol amines
US4145443A (en) * 1977-10-31 1979-03-20 Syntex (U.S.A.) Inc. Bicyclo 3.1.0!hexylethylaminocarbonyl-substituted naphthyloxy cardiovascular agents
US4151297A (en) * 1977-10-31 1979-04-24 Syntex (U.S.A.) Inc. Bicyclo [3.1.0] hexyl-substituted ethylamino carbonyl phenoxy cardiovascular agents
US4163053A (en) * 1977-12-27 1979-07-31 Schering Corporation Anti-hypertensive 5-[2-(substituted anilinoalkylamino)-1-hydroxyalkyl]salicylamides
US4428883A (en) 1981-03-06 1984-01-31 The University Of Kentucky Research Foundation Novel method of administering β-blockers and novel dosage forms containing same
JPS58109461A (ja) * 1981-12-24 1983-06-29 Kowa Co 新規ベンズアミド誘導体
US4503075A (en) * 1982-11-12 1985-03-05 A. Menarini S.A.S. Derivatives of 1-alkylamine-3[4(p-alkyloxy-benzamide)phenoxy]-2-propanol, having beta-sympatholytic activity, their salts, and production processes thereof
FR2607812B1 (fr) * 1986-12-05 1989-04-07 Roussel Uclaf Nouveaux derives du benzamide, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
WO1993012069A1 (en) * 1991-12-16 1993-06-24 Yamanouchi Pharmaceutical Co., Ltd. Novel amino alcohol derivative or salt thereof
US6951962B2 (en) * 2002-04-12 2005-10-04 Hercules Incorporated Oil/grease- and water-sizing agent for treatment of cellulosics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE639158A (de) * 1961-12-05
GB1078852A (en) * 1964-09-30 1967-08-09 Ici Ltd Alkanolamine derivatives

Also Published As

Publication number Publication date
US3676493A (en) 1972-07-11
IE33184L (en) 1970-01-18
GB1269775A (en) 1972-04-06
ZA694631B (en) 1971-02-24
CH533596A (de) 1973-02-15
CH520103A (de) 1972-03-15
BR6910824D0 (pt) 1973-02-22
FR2013209A1 (de) 1970-03-27
IL32640A0 (en) 1969-11-12
ES369624A1 (es) 1971-06-01
DE1936693A1 (de) 1970-01-22
CH539018A (de) 1973-08-31
NO125445B (de) 1972-09-11
AT296256B (de) 1972-02-10
IE33184B1 (en) 1974-04-17
IL32640A (en) 1975-06-25
JPS4842869B1 (de) 1973-12-14
BE736231A (de) 1970-01-19
PL80101B1 (de) 1975-08-30
NL6910914A (de) 1970-01-20

Similar Documents

Publication Publication Date Title
AT298459B (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Phenoxy-2-hydroxy-3-alkylaminopropanen und von deren Säureadditionssalzen
AT299914B (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven, substituierten 3-Carbamoylphenoxy-2-hydroxy-aminopropanen, und von deren Säureadditionssalzen
AT304476B (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Phenoxy-2-hydroxy-3-cycloalkylaminopropanen und ihren Säureadditionssalzen
AT318600B (de) Verfahren zur Herstellung von neuen, racemischen oder optisch aktiven N-(Furyl-methyl)-morphinanen und deren Säureadditionssalzen
AT289078B (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Nitrilophenoxy- oder 1-Alkinyloxyphenoxy-2-hydroxy-3-tert.butylaminopropanen und deren Salzen
AT293354B (de) Verfahren zur Herstellung von neuen 2-Aminomethyladamantanen, sowie deren Säureadditionssalzen
AT298461B (de) Verfahren zur herstellung von neuen racemischen oder optisch aktiven 1-phenoxy-2-hydroxy-3-sek.alkylaminopropanen und von deren saeureadditionssalzen
AT289074B (de) Verfahren zur Herstellung von neuen racemischen oder optisch aktiven substituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen sowie von deren Säureadditionssalzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee